|
|
||||||||




*
Department of Pathology and
Committee on Immunology, University of Chicago, Chicago, IL 60637; and
Center for Mechanistic Biology and Biotechnology, Argonne National Laboratory, Argonne, IL 60439
6S. Aviel et al., submitted for publication.
Newly synthesized Ig chains are known to interact in vivo with the binding protein (BiP), a major peptide-binding chaperone in the endoplasmic reticulum. The predominant interactions between the light chain and BiP are observed early in the folding pathway, when the light chain is either completely reduced, or has only one disulfide bond. In this study, we describe the in vitro reconstitution of BiP binding to the variable domain of light chains (VL). Binding of deliberately unfolded VL was dramatically more avid than that of folded VL, mimicking the interaction in vivo. Furthermore, VL binding was inhibited by addition of ATP, was competed with excess unlabeled VL, and was demonstrated with several different VL proteins. Using this assay, peptides derived from the VL sequence were tested experimentally for their ability to bind BiP. Four peptides from both ß sheets of VL were shown to bind BiP specifically, two with significantly higher affinity. As few as these two peptide sites, one from each ß sheet of VL, are sufficient to explain the association of BiP with the entire light chain. These results suggest how BiP directs the folding of Ig in vivo and how it may be used in shaping the B cell repertoire.
This article has been cited by other articles:
![]() |
Y. Elkabetz, Y. Argon, and S. Bar-Nun Cysteines in CH1 Underlie Retention of Unassembled Ig Heavy Chains J. Biol. Chem., April 15, 2005; 280(15): 14402 - 14412. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Decourt, H. R. Galea, C. Sirac, and M. Cogne Immunologic basis for the rare occurrence of true nonsecretory plasma cell dyscrasias J. Leukoc. Biol., September 1, 2004; 76(3): 528 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Coriu, K. Weaver, M. Schell, M. Eulitz, C. L. Murphy, D. T. Weiss, and A. Solomon A molecular basis for nonsecretory myeloma Blood, August 1, 2004; 104(3): 829 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Coughlan, J. L. Walker, J. C. Cochran, K. D. Wittrup, and J. L. Brodsky Degradation of Mutated Bovine Pancreatic Trypsin Inhibitor in the Yeast Vacuole Suggests Post-endoplasmic Reticulum Protein Quality Control J. Biol. Chem., April 9, 2004; 279(15): 15289 - 15297. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vogen, T. Gidalevitz, C. Biswas, B. B. Simen, E. Stein, F. Gulmen, and Y. Argon Radicicol-sensitive Peptide Binding to the N-terminal Portion of GRP94 J. Biol. Chem., October 18, 2002; 277(43): 40742 - 40750. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Dul, D. P. Davis, E. K. Williamson, F. J. Stevens, and Y. Argon Hsp70 and Antifibrillogenic Peptides Promote Degradation and Inhibit Intracellular Aggregation of Amyloidogenic Light Chains J. Cell Biol., February 20, 2001; 152(4): 705 - 716. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |